StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Abbott Labs (ABT) PT Raised to $125 at Jefferies
October 16, 2024 4:04 PM
Jefferies analyst Matthew Taylor raised the price target on Abbott Labs (NYSE: ABT) to $125.00 (from $120.00) while maintaining a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Next Articles
TD Cowen Reiterates Buy Rating on Abbott Labs (ABT)
October 16, 2024 4:18 PM
JPMorgan Reiterates Overweight Rating on Abbott Labs (ABT)
October 16, 2024 4:12 PM
Abbott Labs (ABT) PT Raised to $130 at Stifel
October 16, 2024 3:21 PM
Abbott Labs (ABT) PT Raised to $128 at Evercore ISI
October 16, 2024 2:42 PM
Abbott Labs (ABT) PT Raised to $139 at BTIG
October 16, 2024 1:13 PM
CFRA Reiterates Buy Rating on Rio Tinto Plc. (RIO:LN) (RIO)
October 16, 2024 12:40 PM
Abbott narrows full-year financial guidance amid strength in medical device sales
October 16, 2024 8:07 AM
Form 8-K ABBOTT LABORATORIES For: Oct 16
October 16, 2024 7:38 AM
Abbott bumps up profit forecast on strong medical device sales
October 16, 2024 7:37 AM
Abbott (ABT) Tops Q3 EPS by 1c, Offers Guidance
October 16, 2024 7:32 AM
Abbott Reports Third-Quarter 2024 Results and Raises Midpoint of Full-Year EPS Guidance Range
October 16, 2024 7:30 AM
Abbott (ABT) October option implied volatility into quarter results
October 15, 2024 11:28 AM
Abbott (ABT) October 117 straddle priced for a move of 3.5% into the expected release before the b
October 15, 2024 1:34 AM
